Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5752 USD | -0.10% | -8.33% | -94.78% |
05-24 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
05-06 | Allarity Therapeutics Says Stockholders' Equity 'Significantly' Exceeds Nasdaq's $2.5 Million Minimum Rule | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.78% | 178K | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- Transcript : Allarity Therapeutics, Inc. - Shareholder/Analyst Call